NanoLogix's
patent pending BNC/BNP™ Technology provides
extremely rapid results for microorganism detection, is
applicable to a variety of liquid, solid, and bio-aerosol
samples, and is based on utilizing the unique features of the
BNC™ Plate.
To
view these new technologies in more detail, please choose from
the product list below.
The bottom line for NanoLogix's BNC/BNP™ Ultra Fast
Identification Technology is that it is a superior
replacement for Petri dishes. Instead of 24-72 hours to
determine the nature of an infection that a patient may have,
the results can be obtained in no more than a few hours.
This new technology can reduce the use of broad spectrum
antibiotic treatment and enable a more rapid application of the
specific antibiotic necessary for treatment. NanoLogix is now
pursuing commercialization of this technology in a number of
potential applications with the goal being to capture a
percentage of the global $2 billion+ Petri dish market.
For national BioDefense
needs, such as the Anthrax attack that happened in the United
States or for battlefield situations, quick and accurate identification of microorganisms is crucial.
NanoLogix believes that our BNC/BNP™ Technology may be
able to make a major contribution to fast, portable and accurate
Anthrax identification.
